STAT+: WTO proposal for Covid diagnostics and therapeutics waiver is abandoned
After 18 months of debate, the World Trade Organization failed to adopt a controversial proposal…
Category: Medicine
Where’s Lilly’s Alzheimer’s approval?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more
Good morning, everyone, and how are you today? We are doing just fine, despite a…
STAT+: Novo Nordisk’s diabetes drug Ozempic cuts risk of kidney disease progression, trial shows
LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney…
.jpg)
Q&A: Microsoft research head explains how generative AI could help doctors be more human
Generative AI is having a moment. Peter Lee, who oversees Microsoft’s approach to health care…
How the U.S. is sabotaging its best tools to prevent deaths in the opioid epidemic
The opioid overdose epidemic has burned through the U.S. for nearly 30 years. Yet for…
Opinion: How ideas from ancient Greece like ‘a bun in the oven’ continue to affect reproductive health policy
On Jan. 22, 1973, the U.S. Supreme Court handed down its decision in Roe v….
Watch: Why fentanyl withdrawal is agony and how medication can prevent it
Over 2 million Americans have opioid use disorder, according to some estimates. Illicit opioids such…
STAT+: Q&A: Nora Volkow on how to get ‘at least 50% less people dying’ from opioid overdose
In 2003, the year Nora Volkow was appointed director of the National Institute on Drug…
First over-the-counter birth control pill in U.S. begins shipping to stores
WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this…
Covid-19 increases risk of developing autoimmune disease, but vaccination helps, large study shows
Having Covid-19 increases a person’s risk of developing an autoimmune disease in the year after…
STAT+: White House is told the big three PBMs are ‘everything wrong with this industry’
As part of its battle to blunt the growing cost of medicines, the White House…
.jpg)
STAT+: ‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling
A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and…
STAT+: White House touts incremental step in Medicare drug price negotiation: counteroffers
WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program…
STAT+: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership
Next stop: Beacon Hill. Governor Maura Healey’s long-awaited plan to double down on state funding…
In a first, fetal cell organoids generated from amniotic fluid, new study reports
As a fetus develops, its body is bathed in amniotic fluid: a warm, salty soup…
Serum Institute of India wants government HPV contract
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: He’s 19 months old and has one of the world’s rarest diseases. His parents are determined to find a cure.
SOMERVILLE — At 19 months old, Lucas Guo has never crawled, walked, or stood by…
STAT+: Longer treatment gave better liver outcomes for MASH patients, Akero drug study shows
Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease…
Opinion: Missing data is making it difficult for the pharmaceutical industry to help LGBTQ+ people
Lack of health data on LGBTQ+ people has real-world consequences. A participant in a 2020…
STAT+: Federal regulators, scrambling to keep up with AI in health care, team up with industry to set standards
At first glance, the Coalition for Health AI looks like any technology lobbying group. Its…
STAT+: Explaining Change Healthcare and the gravity of its cyberattack
The cyberattack on Change Healthcare has fractured the country’s health care payment infrastructure. But it…
STAT+: Medicare is a tricky market for telehealth companies. Why is Talkspace betting on it?
Over the last few years, virtual mental health company Talkspace has been on a relentless…
Q&A: Stem cell biologist predicts human embryo models could pave the way to organ transplants
A lot happens in the first month of human embryo development as a single cell…
STAT+: Congress gives doctors Medicare pay bump, sets up December fight in new funding package
WASHINGTON — Doctors will get a 1.68% pay hike in Medicare starting March 9 under…
Opinion: Too many donor organs go to waste. Here’s how to get them into the patients who need them
As I was getting ready to perform a kidney transplant from a deceased donor on…
STAT+: RaDonda Vaught, nurse that accidentally killed patient, to speak at CommonSpirit event on patient safety
CommonSpirit Health is hosting an educational event this month featuring RaDonda Vaught, the Tennessee nurse…
CVS and Walgreens plan to start dispensing abortion pill mifepristone soon
The drugstore chains CVS Health and Walgreens plan to start dispensing an abortion pill in a few…
STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies
A growing number of alternative pharmacies — such as those run by Costco, Amazon, and…
STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation
WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case…
Why do some women experience UTI pain with no clear infection? A mouse study offers clues
Each year, more than 400 million urinary tract infections occur in people around the globe….
CDC eases isolation guidance for Covid and other respiratory illnesses
The Centers for Disease Control and Prevention is “sunsetting” its advice that people sick with…
STAT+: Pharmalittle: We’re reading about RSV vax link to GSB, a Pfizer donation, and more
And so, another working week will soon draw to a close. Not a moment too…
Despite good data, Ironwood’s shares plummet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships
Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching…
Opinion: New federal guidance is hurting cancer patients, especially those in rural areas
I recently started a patient with metastatic triple-positive breast cancer patient on a targeted therapy…
Q&A: AMA’s chief health equity officer on ridding medicine of racial essentialism
In the aftermath of the police murder of George Floyd and subsequent Black Lives Matter…
STAT+: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices
Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services….
STAT+: Here are the cancer drugs Pfizer thinks could reignite investors’ interest
Pfizer spent more than four hours Thursday laying out its oncology program to investors. But…
More than 1 billion people have obesity, including 159 million young people, study estimates
More than 1 billion people — or one in eight people worldwide — are now…
Vote now in STAT Madness 2024
Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and…
STAT+: Change Healthcare cyber attack outage could persist for weeks, UnitedHealth Group executive implies
The outage caused by the Change Healthcare cyberattack could last weeks, a top UnitedHealth executive…
RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest
The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be…
STAT+: What does America’s crackdown on Chinese firms mean for the U.S. biotech sector?
WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American…
Listen: Legal insider trading, booming biotech stocks, & the next GLP-1
Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy? We cover…
House looks to weaken Medicare negotiation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
The next act for a biotech rainmaker
Want to stay on top of the science and politics driving biotech today? Sign up to…
Flu vaccine offering decent levels of protection this winter, new data show
Flu vaccine appears to be offering reasonable levels of protection this winter, with particularly strong…
STAT+: Pharmalittle: We’re reading about White House eyeing PBMs, Pfizer CEO’s frustrations, and more
Top of the morning to you, and a fine one it is. Cold winds and…